Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Standard Motor Products heads into its October 28 earnings report with short interest at its highest level in six weeks and a clean activist filing on the register, two facts that sit awkwardly alongside an options market signalling almost no demand for downside protection.
The short interest story is the most striking development of the past month. At 5.1% of free float, the position is modest in absolute terms, but it has grown 24% over the past 30 days, climbing from around 910,000 shares in early September to 1.13 million now. The bulk of that build happened in a single step around September 23, when shares short jumped roughly 200,000 in one session. That move has since held, suggesting it was deliberate repositioning rather than noise. Borrow costs remain cheap at 0.66%, and availability is extremely loose at nearly 1,900%, meaning new shorts face no friction entering the position. The borrow market offers no hint of a squeeze setup.
Options tell a different story from the shorts. The put/call ratio has drifted lower in recent weeks, landing at 0.11, well below its 20-day average of 0.12 and close to the bottom of its 52-week range (low of 0.03, high of 1.09). Call activity dominates the options book. That contradicts the short rebuild and suggests two distinct groups of investors are leaning in opposite directions ahead of the print: one adding short exposure through the stock borrow market, another expressing optimism through calls.
Analyst coverage is thin and data is stale. The most recent changes on record date from late 2025, when Freedom Broker raised its target to $47 and Roth Capital reiterated a Buy at $49. Against a current price of $36.67, the mean price target of $50 implies roughly 36% upside, though with the consensus data now over a year old, those figures carry limited weight. Valuation multiples at least look undemanding: the stock trades at a P/E of 7.8 and an EV/EBITDA of 6.6, with the EV/EBIT factor score ranking in the 77th percentile of the universe. The dividend score sits in the 90th percentile, though dividend history in the data is too old to rely on.
One name worth watching on the register is GAMCO Asset Management, which holds a Schedule 13D/A on SMP, a filing type that denotes active intent rather than a passive stake. GAMCO's last disclosed position was 4% of shares as of April 2025. The stock's top institutional holder is BlackRock with around 18% of shares, and GAMCO's fellow value-oriented firm Royce & Associates holds roughly 5.4%. All have been adding incrementally. On the insider side, the recent activity runs the other way: the CLO and Chief Commercial Officer both sold shares in August and September at prices between $38.71 and $39.24, above where the stock trades now, in transactions not covered by 10b5-1 plans. The 90-day insider net is negative at roughly -$918,000.
The ORTEX short score of 47 sits near the middle of its range and has drifted fractionally lower over the past week. Among peers, PHIN and DORM are both down 3% on the week, broadly in line with SMP's own 2.3% decline, while FOXF and CPS have fallen harder at 3.2% and 3.8% respectively, suggesting sector-wide softness rather than stock-specific selling.
With earnings 18 days out, the question is whether the short rebuild from September was positioned ahead of the report or is simply macro-driven sector exposure. The two most recent prints produced modest positive moves (around 2% and 0.3% on day one), which gives the options market some basis for its relaxed put/call ratio. The October 28 release will either validate the short re-entry or face a lightly hedged long base.
See the live data behind this article on ORTEX.
Open SMP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
